Follow on Twitter
RSS updates
Register for email updates
Open Access
Subscription or Fee Access
Table of Contents
Editorial
| Intellectual property and biotechnology innovation: To protect or not protect? |
PDF
|
| Yali Friedman |
Commentary
| The correlation between medical tourism and biotechnology |
PDF
|
| David G Vequist IV, Erika Valdez |
| The VC manifesto: Special pleading for a damaged cause: Commentary on Simon Witney interview |
PDF
|
| William Bains |
Articles
| Innovate America: The Technology Innovation Program at NIST |
PDF
|
| Andrew S Klein, Mrunal S Chapekar |
| Valuation of complex license contracts |
PDF
|
| Ralph Villiger, Boris Bogdan |
| How can pharmaceutical and biotechnology companies maintain a high profitability? |
PDF
|
| Klaus J Nickisch, Joachim M Greuel, Kerstin M Bode-Greuel |
| Multiyear patterns regarding the relative availability of venture capital for the US biotechnology industry |
PDF
|
| J Leslie Glick |
| Building biotechnology teams: Personality does matter |
PDF
|
| Anne S York, Kim A McCarthy, Todd C Darnold |
| Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement |
PDF
|
| Rob Hanes, Damon Borich |
Legal and Regulatory Updates
| Legal and Regulatory Update |
PDF
|
| Gerry Kamstra, John Wilkinson |
Book Reviews
| Book Review: Genomics & society: Legal, ethical and social dimensions |
PDF
|
| Dominic Clark |
| Book Review: Commercialization of innovative technologies: Bringing good ideas to the marketplace |
PDF
|
| Arlen D Meyers |
| Book Review: Biotech funding trends: Insights from entrepreneurs and investors |
PDF
|
| J Leslie Glick |
Copyright © thinkBiotech LLC